MedTrace Logo

Conventional Photodynamic Therapy vs. Painless Photodynamic Therapy for Moderate or Severe Acne

NCT03961607 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-05-23

No results posted yet for this study

Summary

This study is being done to compare a new, continuous illumination and short Incubation time regimen of aminolevulinic acid photodynamic therapy#ALA- PDT) to a conventional regimen for treatment of Moderate or Severe Acne. The hypothesis is that the continuous illumination approach will be less or even no painful, but equally efficacious, as the old regimen.

Conditions

Interventions

PROCEDURE

Aminolevulinic acid photodynamic therapy

Aminolevulinic acid photodynamic therapy

Sponsors & Collaborators

  • Shanghai Dermatology Hospital

    lead OTHER

Principal Investigators

  • Xiuli Wang, PhD, MD · Shanghai Skin Disease Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-10
Primary Completion
2019-12-30
Completion
2019-12-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03961607 on ClinicalTrials.gov